Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Verstegen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Developments in early-stage NSCLC: advances in radiotherapyN E Verstegen, F J Lagerwaard, S Senan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysisN E Verstegen, J W A Oosterhuis, D A Palma, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Developments in early-stage NSCLC: advances in radiotherapyN E Verstegen, F J Lagerwaard, S Senan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysisN E Verstegen, J W A Oosterhuis, D A Palma, et al.
Pageof 1